Resectable Pancreatic Carcinoma

Objective The associations between oral diseases and increased risk of pancreatic cancer have been reported in several… Expand

BACKGROUND & AIMS Lack of detection technology for early pancreatic cancer invariably leads to a typical clinical presentation of… Expand

PURPOSE We conducted a phase II trial to assess the outcomes of patients who received preoperative gemcitabine-based… Expand

BACKGROUND Patients with borderline resectable pancreatic adenocarcinoma (PA) include those with localized disease who have tumor… Expand

CONTEXT The role of adjuvant therapy in resectable pancreatic cancer is still uncertain, and no recommended standard exists… Expand

With recent advances in pancreatic imaging and surgical techniques, a distinct subset of pancreatic tumors is emerging that blurs… Expand

Patients with inoperable pancreatic cancer have a dismal prognosis with a mean life expectancy of 3–6 months. New treatment… Expand

BACKGROUND To compare operative morbidity, mortality, quality of life, and survival after pancreatoduodenectomy (PD) versus… Expand

OBJECTIVE We sought to determine the impact of positron emission tomography/computed tomography (PET/CT) on the management of… Expand

BACKGROUND The role of adjuvant treatment in pancreatic cancer remains uncertain. The European Study Group for Pancreatic Cancer… Expand